Liabilities / Assets
91st percentile
Higher debt load relative to assets than 91% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.93x
Liabilities / Revenue
84th percentile
Higher debt load relative to revenue than 84% of similar nonprofits.
Net Margin
34th percentile
Higher net margin than 34% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
14th percentile
Faster asset growth than 14% of similar nonprofits.
Revenue Growth
11th percentile
Faster revenue growth than 11% of similar nonprofits.
Balance Sheet
Assets
Down$3,858,975
Down $419,506 (-9.8%) from 2017
Net Assets
Down$253,675
Down $59,193 (-19%) from 2017
Liabilities
Down$3,605,300
Down $360,313 (-9.1%) from 2017
Revenue And Expenses
Revenue
Down$4,107,224
Down $1,406,260 (-26%) from 2017
Expenses
Down$4,180,948
Down $1,144,827 (-21%) from 2017
Net Income
Down-$73,724
Down $261,433 (-139%) from 2017
Historical Trend
Filing Detail Status
This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Aug 1, 2017 to Jul 31, 2018
Mission and Program Overview
Mission
To recruit the world's best research scientists and clinicians to work together toward an understanding of and the first effective treatments for als (amyotrophic lateral sclerosis) also known as lou gehrig's disease.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2018 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $3,858,975
- Liabilities
- $3,605,300
- Net assets
- $253,675
- Revenue
- $4,107,224
- Expenses
- $4,180,948
- Net income
- -$73,724